The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid

被引：0
作者：
P. R. Donald
D. P. Parkin
H. I. Seifart
H. S. Schaaf
P. D. van Helden
C. J. Werely
F. A. Sirgel
A. Venter
J. S. Maritz
机构：
[1] Stellenbosch University,Paediatrics and Child Health, Faculty of Health Sciences
[2] Stellenbosch University,Department of Pharmacology, Faculty of Health Sciences
[3] Stellenbosch University,Department of Biology and Human Genetics, and the MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences
[4] Biostatistics Unit of the South African Medical Research Council,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Isoniazid; Early bactericidal activity; -acetyltransferase-2; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 639
页数：6
相关论文
共 50 条
  • [1] The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid
    Donald, P. R.
    Parkin, D. P.
    Seifart, H. I.
    Schaaf, H. S.
    van Helden, P. D.
    Werely, C. J.
    Sirgel, F. A.
    Venter, A.
    Maritz, J. S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (07) : 633 - 639
  • [2] N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians
    Aklillu, Eleni
    Antonio Carrillo, Juan
    Makonnen, Eyasu
    Bertilsson, Leif
    Djordjevic, Natasa
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (07) : 903 - 911
  • [3] N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians
    Eleni Aklillu
    Juan Antonio Carrillo
    Eyasu Makonnen
    Leif Bertilsson
    Natasa Djordjevic
    European Journal of Clinical Pharmacology, 2018, 74 : 903 - 911
  • [4] Pharmacokinetics of isoniazid in relation to NAT2 genotypes
    Cao, Xiaomei
    Li, Jinheng
    Chen, Bing
    Leng, Weiwei
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 211 - 211
  • [5] NAT2 Genotype and Isoniazid Medication in Children
    Golka, Klaus
    Selinski, Silvia
    EBIOMEDICINE, 2016, 11 : 11 - +
  • [6] Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
    Thomas, Levin
    Raju, Arun Prasath
    Chaithra
    Sekhar, M. Sonal
    Varma, Muralidhar
    Saravu, Kavitha
    Banerjee, Mithu
    Sanju, S. V. Chidananda
    Mallayasamy, Surulivelrajan
    Rao, Mahadev
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (10) : 1535 - 1553
  • [7] Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
    Levin Thomas
    Arun Prasath Raju
    Sonal Sekhar Chaithra
    Muralidhar M
    Kavitha Varma
    Mithu Saravu
    Chidananda Sanju Banerjee
    Surulivelrajan SV
    Mahadev Mallayasamy
    European Journal of Clinical Pharmacology, 2022, 78 : 1535 - 1553
  • [8] Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients
    Rana, S. V.
    Ola, R. P.
    Sharma, Sanjeev K.
    Arora, S. K.
    Sinha, S. K.
    Pandhi, P.
    Singh, K.
    HEPATOLOGY INTERNATIONAL, 2012, 6 (01) : 397 - 402
  • [9] Comparison between acetylator phenotype and genotype polymorphism of n-acetyltransferase-2 in tuberculosis patients
    S. V. Rana
    R. P. Ola
    Sanjeev K. Sharma
    S. K. Arora
    S. K. Sinha
    P. Pandhi
    K. Singh
    Hepatology International, 2012, 6 : 397 - 402
  • [10] Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis
    Verhagen, Lilly M.
    Coenen, Marieke J. H.
    Lopez, Diana
    Garcia, Juan F.
    de Waard, Jacobus H.
    Schijvenaars, Mascha M. V. A. P.
    Hermans, Peter W. M.
    Aarnoutse, Rob E.
    PHARMACOGENOMICS, 2014, 15 (03) : 285 - 296
12345